arrow_rightarrow_righticon_excelicon_pficon_ppticon_wordmagnifier

MONDAY 21 MARCH 2022

Monday 21 Mar

08:00

Breakfast sessions

Plenary

09:00

WGS - routine diagnostics?

Prof. Dr. Gerrit Meijer, NKI Amsterdam, the Netherlands

09:30

ctDNA - routine diagnostics?

10:00

Pauze

10:15

Parallel symposium 20-24

Symposium 20: Tailor made medicine

10:15

Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer

Louis Vermeulen, Amsterdam University Medical Centers, the Netherlands

10:30

Integrated Omics of Metastatic Colorectal Cancer

Rong Zeng, China

10:45

Clinical relevance of ex-vivo drug testing

Jeanine Roodhart, UMC Utrecht, the Netherlands

Symposium 21: Clinical genetics

10:15

Chemoprevention in Lynch syndrome-CAPP trials

10:30

Type of surgery in Lynch patients

10:45

MSI-tests- new technical developments

Symposium 22: CRC and IBD-case presentation

10:15

The work-up of colitis associated dysplasia

Prof, Dr. Bas Oldenburg, UMC Utrecht, the Netherlands

10:30

Local treatment versus segmental resection

10:45

Extend of surgery for IBD related dysplasia/ cancer

Symposium 23: Risk estimation of adverse oncological outcome in T1 CRC

10:15

Epidemiology of lymph node metastasis and recurrences

Dr. Sjoerd Elias, UMC Utrecht, the Netherlands

10:30

Pathways to development of metastasis

Philip Dunne, The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, United Kingdom

10:45

What is the optimal model for rsk assesment of T1 CRCs

Dr. Miangela Lacle, UMC Utrecht, the Netherlands

Symposium 24: Challenges and benefits of prospective patient accrual for translational research

10:15

How to accrue all CRC patients for translational research

Geraldine Vink, the Netherlands

10:30

Challenges of intl trials [FOxTROT]

Jenny Seligmann, University of Leeds, United Kingdom

10:45

Modeling health benefit

Veerle Coupe, Amsterdam UMC, the Netherlands

11:00

Parallel symposium 25-29

Symposium 25: Rectal recurrences

11:00

Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy

Stephen Shiao

11:15

Induction therapy: Start with radiotherapy or chemotherapy?

Prof. Dr. Thierry Conroy, Institut de Cancérologie de Lorraine, France

11:30

Salvage surgery

Eva Voogt, Catharina Hospital, the Netherland

11:45

Selected Abstracts

Symposium 26: Rectal surgery- the preferred modality

11:00

taTME

11:15

Robotic surgery

Jim Khan, University of Portsmouth, United Kingdom

11:30

Laparoscopic surgery

Dr. Felix Aigner, Graz, Austria

11:45

Selected Abstracts

Symposium 27: T4 CRCs (diagnosis and biology)

11:00

Selection of T4 tumors based on CT scan

Prof. Gina Brown, King’s College Hospital School of Medicine, London, United Kingdom

11:15

Pathways to peritoneal metastasis and potential targets of treatment

Prof. Dr. Andre d'Hoore, UZ Leuven, Belgium

11:30

Surgical aspects ofmultivisceral resections

11:45

Selected abstracts

Symposium 28: Alternative strategies for completion surgery

11:00

R1/Rx without risk factors: completion surgery or local scar excision

Dr. Leon Moons, UMC Utrecht, the Netherlands

11:15

High risk T1 rectal cancer- intensive surveillance or completion surgery

Chris Cunningham, Oxford University Hospitals, United Kingdom

11:30

Adjuvant radiotherapy for high risk rectal cancers

Dr. Jurriaan Tuynman, Amsterdam UMC, the Netherlands

11:45

Selected Abstracts

Symposium 29: Capture, view, query clinical, imaging and molecular data

11:00

Capturing clinical images: XNAT

11:15

Capturing pathology images: SlideScore

11:30

cBioPortal - demo

12:15

Sponsored Lunch sessions

Chemotherapy & Immunotherapy

13:00

Latest developments in systemic therapy

Prof. Dr. Eric Van Cutsem, UZ Leuven, Belgium

13:20

Immunotherapy

Prof. Andre Thierry, Hospital Saint Antoine, France

13:40

KRAS inhibition in mCRC

Judith Leopold, University of Michigan Rogel Cancer Center, United States

Parallel symposium 30-24

Symposium 30: Immunotherapy

14:15

TGF-b inhibition to potentiate immunotherapy

Alexandre Calon, IRB Barcelona, Spain

14:30

Neo-adjuvant immunotherapy (NICHE trial)

Miriam Chalabi, Netherlands Cancer Institute, Amsterdam

14:45

The Intestinal Microbiota in Colorectal Cancer

Prof, Dr. Herbert Tilg, Medical University of Innsbruck, Austria

Symposium 31: Abdominal Imaging- the new era

14:15

Staging rectal cancer with MRI- beyond the TNM classication

Prof. Gina Brown, Professor of Gastrointestinal Cancer Imaging

14:30

functional imaging- FAPI scan

Prediction of lymph node metastasis

Symposium 32: Peritoneal metastases

14:15

Preclinical/basic aspects and mechanisms of PM or IP drug delivery

Prof. Dr. Wim Ceelen, UZ Gent, Belgium

14:30

Synchronous and metachronous PM; Late effects after CRS+HIPEC (Iversen)

Prof. Dr. Lene Iversen, Aarhus Universitetshospital, Denmark

14:45

Update on clinical trials

Peter Cashin, Uppsala University, Sweden

Symposium 33: Local excision of T1 CRC which plane of resection

14:15

Submucosa

Mathieu Pioche, CHU de Lyon, France

14:30

Intermuscular

Dr. Leon Moons, UMC Utrecht, the Netherlands

14:45

Full thickness

15:00

Discussion with online questions

Symposium 34: Novel biomarkers for early detection

14:15

Novel biomarkers for early detection

Dr. Beatriz Carvalho, Netherlands Cancer Institute

14:30

CRC screening

Carlo Senore, Italy

14:45

Selected Abstracts

Parallel symposium 35 - 39

Symposium 35: Colorectal lung metastases

15:15

Local treatment of lung metastases Yes or NO (Battle)

15:30

T.B.C.

15:45

T.B.C.

16:00

Selected Abstracts

Symposium 36: T4 tumors and adjuvant treatment

15:15

Prevention of peritoneal metastases from colorectal cancer

Prof. Paolo Sammartino, Italy

15:30

Is there a place for Prohylactic HIPEC

Alvaro Arjona-Sanchez, Hospital Universitario Reina Sofía, Spain

16:00

Is there a role for second look surgery

Prof. dr. Pieter Tanis, the Netherlands

Symposium 37: AI in pathology - the new predictor of survival

15:15

Pathomics- Stage II/III CRC

15:30

Pathomics-liver metastasis

15:45

pathomics and biology-

16:00

AI in pathology

Symposium 38: New developments in local resection techniques

15:15

Pattern of recurrence

Dr. Jurjen Boonstra, Leiden UMC, the Netherland

15:30

Surveillance strategies for the Colon

Prof. Cesare Hassan, Humanitas Rozzano, Italy

15:45

Surveillance strategies for the rectum

Prof. Antonino Spinelli, Humanitas Research Hospital

16:00

Selected Abstracts

Symposium 39: AI in pathology - the new predictor of survival

15:15

Pathomics- Stage II/III CRC

Håvard Emil Greger Danielsen, Oslo University Hospital, Norway

15:30

Pathomics-liver metastasis

15:45

Pathomics and biology

Prof. Dr. Viktor Koelzer, University of Zurich, Switzerland

16:00

AI in pathology

Dr. Jeroen van der Laak, Radboud UMC, the Netherlands

16:30

pauze

16:45

Neo(adjuvant) treatment of colon carcinomas

Miriam Chalabi, Netherlands Cancer Institute, Amsterdam